We are live on
!
Find out more
OAC
OMERS Administration Corp Portfolio holdings
AUM
$15.6B
1-Year Est. Return
24.73%
This Fund
S&P 500
This Quarter
Est. Return
+4.3%
1 Year Est. Return
+24.73%
3 Year Est. Return
+76.27%
5 Year Est. Return
+102.19%
10 Year Est. Return
+295.96%
AUM
$14B
AUM Growth
+$69M
(+0.49%)
Cap. Flow
-$272M
Cap. Flow
% of AUM
-1.94%
Top 10 Holdings %
Top 10 Hldgs %
36.83%
Holding
1,428
New
293
Increased
220
Reduced
212
Closed
398
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xcel Energy
XEL
|
+$139M |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$136M |
| 3 |
Manulife Financial
MFC
|
+$84.9M |
| 4 |
Royal Bank of Canada
RY
|
+$81.4M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$368M |
| 2 |
Duke Energy
DUK
|
+$141M |
| 3 |
Salesforce
CRM
|
+$139M |
| 4 |
Abbott
ABT
|
+$120M |
| 5 |
Accenture
ACN
|
+$77.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.1% |
| 2 | Financials | 20.47% |
| 3 | Industrials | 11.2% |
| 4 | Consumer Discretionary | 9.32% |
| 5 | Healthcare | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Prelude Therapeutics
PRLD
$310M
| $212K | ﹤0.01% |
+73,000
| New | +$123K |
|
902
Cabaletta Bio
CABA
$444M
| $209K | ﹤0.01% |
+95,400
| New | +$236K |
|
903
Stoneridge
SRI
$210M
| $209K | ﹤0.01% |
+36,071
| New | +$227K |
|
|
AVBC
904
Avidia Bancorp
AVBC
$402M
| $208K | ﹤0.01% |
+12,400
| New | +$194K |
|
905
Amtech Systems
ASYS
$269M
| $208K | ﹤0.01% |
+16,600
| New | +$150K |
|
906
Lexeo Therapeutics
LXEO
$351M
| $208K | ﹤0.01% |
+20,900
| New | +$191K |
|
|
TGEN
907
Tecogen Inc
TGEN
$99.9M
| $207K | ﹤0.01% |
+42,000
| New | +$315K |
|
908
Teleflex
TFX
$5.8B
| $205K | ﹤0.01% |
1,679
| – | – |
|
909
Paylocity
PCTY
$6.97B
| $205K | ﹤0.01% |
1,342
| – | – |
|
|
TONX
910
TON Strategy Co
TONX
$189M
| $205K | ﹤0.01% |
+102,800
| New | +$376K |
|
911
Nautilus Biotechnolgy
NAUT
$211M
| $204K | ﹤0.01% |
+104,785
| New | +$172K |
|
912
Ovid Therapeutics
OVID
$439M
| $204K | ﹤0.01% |
+125,300
| New | +$193K |
|
|
AIFC
913
AI Financial Corp
AIFC
$55.6M
| $204K | ﹤0.01% |
185,600
-146,200
| -44% | -$282K |
|
914
Coya Therapeutics
COYA
$99.9M
| $200K | ﹤0.01% |
+34,500
| New | +$210K |
|
|
IMDX
915
Insight Molecular Diagnostics
IMDX
$152M
| $196K | ﹤0.01% |
+26,164
| New | +$148K |
|
|
SUIG
916
Sui Group Holdings
SUIG
$72.8M
| $196K | ﹤0.01% |
117,100
+99,400
| +562% | +$257K |
|
917
Stem
STEM
$50M
| $190K | ﹤0.01% |
+12,600
| New | +$241K |
|
918
UiPath
PATH
$6.02B
| $189K | ﹤0.01% |
11,537
| – | – |
|
919
Verrica Pharmaceuticals
VRCA
$91.9M
| $188K | ﹤0.01% |
+22,600
| New | +$125K |
|
920
Elicio Therapeutics
ELTX
$78.8M
| $187K | ﹤0.01% |
+23,500
| New | +$213K |
|
|
NEXN
921
Nexxen International
NEXN
$571M
| $185K | ﹤0.01% |
28,347
-2,100
| -7% | -$15.6K |
|
|
STEX
922
Streamex Corp
STEX
$76.9M
| $183K | ﹤0.01% |
+60,400
| New | +$270K |
|
923
PepGen
PEPG
$131M
| $180K | ﹤0.01% |
+27,600
| New | +$143K |
|
|
FWDI
924
Forward Industries Inc
FWDI
$302M
| $177K | ﹤0.01% |
+26,800
| New | +$344K |
|
|
IRD
925
Opus Genetics
IRD
$277M
| $177K | ﹤0.01% |
+87,900
| New | +$178K |
|
Similar funds
EH
NMO
HWM
EF
LCIP
OMERS Administration Corp's Q4 2025 Portfolio in Review
As of Q4 2025, OMERS Administration Corp held 1,428 positions worth $14B, up 0.49% from $14B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
OMERS Administration Corp's Q4 2025 filing shows 293 new, 220 increased, 212 reduced and 398 closed positions. Its largest new stake was Manulife Financial: 2,500,006 shares worth $90.9M. The largest sale was Vanguard S&P 500 ETF, an estimated $368M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Financials and Industrials.
- OMERS Administration Corp's largest Q4 2025 buy was Manulife Financial: 2,500,006 shares worth $90.9M.
- OMERS Administration Corp added most to Xcel Energy in Q4 2025, an estimated $139M increase.
- OMERS Administration Corp's biggest Q4 2025 reduction was Duke Energy, cutting an estimated $141M.
- OMERS Administration Corp fully exited Vanguard S&P 500 ETF in Q4 2025, selling an estimated $368M.
- OMERS Administration Corp's ten largest holdings make up 37% of its $14B portfolio in Q4 2025.
- OMERS Administration Corp opened 293 new positions and closed 398 in Q4 2025.
- OMERS Administration Corp's portfolio value rose 0.49% quarter-over-quarter to $14B.
Based on OMERS Administration Corp's 13F filing for Q4 2025, filed 13 Feb 2026.